Cure Me

03/09/2022

Fewer than 8 hours of sleep increased the risk among adolescents aged 12 to 16 years of being obese or overweight, according to findings presented at the Congress 2022

27/08/2022

19/08/2022

Older patients with chronic kidney disease (CKD) who were administered at higher than recommended doses were more likely to be hospitalized.

Read More:

19/08/2022

Many serious patient illnesses and deaths linked to poor quality compounded drugs have occurred since the 2012 fungal meningitis outbreak. In response, FDA has established an Incidents Program to identify and prevent outbreaks through surveillance of adverse events and product quality incidents. This effort has led to many actions by FDA including the issuance of compounding risk alerts to inform health care professionals, compounders and consumers about risks associated with compounded drugs, including information on adverse events, outbreaks or product quality. These are intended to alert stakeholders of the risks so that practitioners can more effectively protect patients from unsafe, ineffective and poor-quality compounded medicines.

Resource: twitter